These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
635 related items for PubMed ID: 19321928
1. Trends in transfusion-transmitted viral infections from 2001 to 2006 in Ibadan, Nigeria. Fasola FA, Kotila TR, Akinyemi JO. Intervirology; 2008; 51(6):427-31. PubMed ID: 19321928 [Abstract] [Full Text] [Related]
2. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus. Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, Geusendam G, Gubbe K, Mahnhardt C, Mayr-Wohlfart U, Pichl L, Roth WK, Schmidt M, Seifried E, Wright DJ, German Red Cross NAT Study Group. Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173 [Abstract] [Full Text] [Related]
3. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. N Engl J Med; 1996 Jun 27; 334(26):1685-90. PubMed ID: 8637512 [Abstract] [Full Text] [Related]
4. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania. Matee MI, Lyamuya EF, Mbena EC, Magessa PM, Sufi J, Marwa GJ, Mwasulama OJ, Mbwana J. East Afr Med J; 1999 Mar 27; 76(3):167-71. PubMed ID: 10442119 [Abstract] [Full Text] [Related]
5. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Kafi-abad SA, Rezvan H, Abolghasemi H, Talebian A. Transfusion; 2009 Oct 27; 49(10):2214-20. PubMed ID: 19527477 [Abstract] [Full Text] [Related]
6. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R. Transfusion; 2009 Jun 27; 49(6):1115-25. PubMed ID: 19309474 [Abstract] [Full Text] [Related]
9. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Velati C, Romanò L, Fomiatti L, Baruffi L, Zanetti AR, SIMTI Research Group. Transfusion; 2008 Oct 27; 48(10):2205-13. PubMed ID: 18631163 [Abstract] [Full Text] [Related]
10. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services. O'Brien SF, Yi QL, Fan W, Scalia V, Kleinman SH, Vamvakas EC. Transfusion; 2007 Feb 27; 47(2):316-25. PubMed ID: 17302779 [Abstract] [Full Text] [Related]
11. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy. Gonzalez M, Règine V, Piccinini V, Vulcano F, Giampaolo A, Hassan HJ. Transfusion; 2005 Oct 27; 45(10):1670-5. PubMed ID: 16181219 [Abstract] [Full Text] [Related]
12. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009. Al Shaer L, AbdulRahman M, John TJ, AlHashimi A. Transfusion; 2012 Nov 27; 52(11):2300-9. PubMed ID: 22691239 [Abstract] [Full Text] [Related]
13. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS). Glynn SA, Kleinman SH, Schreiber GB, Busch MP, Wright DJ, Smith JW, Nass CC, Williams AE. JAMA; 2000 Jul 12; 284(2):229-35. PubMed ID: 10889598 [Abstract] [Full Text] [Related]
14. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004. Shang G, Seed CR, Wang F, Nie D, Farrugia A. Transfusion; 2007 Mar 12; 47(3):529-39. PubMed ID: 17319836 [Abstract] [Full Text] [Related]
15. Seroprevalence of transfusion-transmissible infections (HBV, HCV, syphilis and HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria; an eleven years evaluation. Okoroiwu HU, Okafor IM, Asemota EA, Okpokam DC. BMC Public Health; 2018 May 22; 18(1):645. PubMed ID: 29788937 [Abstract] [Full Text] [Related]
16. Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors? Wang B, Schreiber GB, Glynn SA, Kleinman S, Wright DJ, Murphy EL, Busch MP, Retrovirus Epidemiology Donor Study. Transfusion; 2005 Jul 22; 45(7):1089-96. PubMed ID: 15987352 [Abstract] [Full Text] [Related]
17. Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique. Cunha L, Plouzeau C, Ingrand P, Gudo JP, Ingrand I, Mondlane J, Beauchant M, Agius G. J Med Virol; 2007 Dec 22; 79(12):1832-40. PubMed ID: 17935167 [Abstract] [Full Text] [Related]
18. Prevalence and Trends of Transfusion-Transmissible Viral Infections among Blood Donors in South of Iran: An Eleven-Year Retrospective Study. Farshadpour F, Taherkhani R, Tajbakhsh S, Gholizadeh Tangestani M, Hajiani G, Sharifi N, Taherkhani S, Nejadbolkheyr A. PLoS One; 2016 Dec 22; 11(6):e0157615. PubMed ID: 27309959 [Abstract] [Full Text] [Related]
19. Prevalence and trends of markers of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in Delhi blood donors: a hospital based study. Pahuja S, Sharma M, Baitha B, Jain M. Jpn J Infect Dis; 2007 Nov 22; 60(6):389-91. PubMed ID: 18032841 [Abstract] [Full Text] [Related]
20. Prevalence of transmissible blood infections among blood donors at the University of Maiducuri Teaching Hospital, Maiduguri, Nigeria. Chikwem JO, Mohammed I, Okara GC, Ukwandu NC, Ola TO. East Afr Med J; 1997 Apr 22; 74(4):213-6. PubMed ID: 9299819 [Abstract] [Full Text] [Related] Page: [Next] [New Search]